493 related articles for article (PubMed ID: 30173737)
1. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
[TBL] [Abstract][Full Text] [Related]
2. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
[TBL] [Abstract][Full Text] [Related]
3. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
Yang S; Oh T; Cho H; Chae C
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of concurrent vaccination with modified-live PRRSV-1 and PRRSV-2 vaccines against heterologous dual PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
Yang S; Oh T; Kang I; Park SJ; Chae C
Vet Microbiol; 2019 Dec; 239():108497. PubMed ID: 31767085
[TBL] [Abstract][Full Text] [Related]
5. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
[TBL] [Abstract][Full Text] [Related]
6. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine protects late-term pregnancy gilts against a heterologous PRRSV-2 challenge.
Yang S; Kang I; Cho H; Oh T; Park KH; Min KD; Chae C
Can J Vet Res; 2020 Jul; 84(3):172-180. PubMed ID: 32801451
[TBL] [Abstract][Full Text] [Related]
7. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
[TBL] [Abstract][Full Text] [Related]
8. Reproductive performance of gilts following vaccination and subsequent heterologous challenge with European strains of porcine reproductive and respiratory syndrome virus.
Scortti M; Prieto C; Simarro I; Castro JM
Theriogenology; 2006 Nov; 66(8):1884-93. PubMed ID: 16806451
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a commercial porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine against heterologous PRRSV-1 and PRRSV-2 challenge in late-term pregnant gilts.
Oh T; Kim H; Park KH; Jeong J; Kang I; Yang S; Chae C
Can J Vet Res; 2019 Oct; 83(4):248-254. PubMed ID: 31571723
[TBL] [Abstract][Full Text] [Related]
10. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
[TBL] [Abstract][Full Text] [Related]
12. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
[TBL] [Abstract][Full Text] [Related]
13. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
Park C; Choi K; Jeong J; Chae C
Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
[TBL] [Abstract][Full Text] [Related]
14. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV.
Scortti M; Prieto C; Alvarez E; Simarro I; Castro JM
Vet Rec; 2007 Dec; 161(24):809-13. PubMed ID: 18083979
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
[TBL] [Abstract][Full Text] [Related]
16. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
Charerntantanakul W; Pongjaroenkit S
Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
Park C; Seo HW; Han K; Kang I; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
[TBL] [Abstract][Full Text] [Related]
20. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
